Primary Immunodeficiency Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Rituximab and Abatacept Effectiveness in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies.
Condition: Interstitial Lymphocytic Lung Disease Interventions: Drug: Rituximab; Drug: Abatacept Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2020 Category: Research Source Type: clinical trials
A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Na ïve Participants With Primary Immunodeficiency
Condition: Primary Immunodeficiency Intervention: Biological: IGSC 20% Sponsor: Grifols Therapeutics LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2020 Category: Research Source Type: clinical trials
